121 related articles for article (PubMed ID: 2873028)
1. Plasma somatostatin-like immunoreactivity responses to a mixed meal and the heterogeneity in healthy and non-insulin-dependent (NIDDM) diabetics.
Miyazaki K; Funakoshi A; Ibayashi H
Endocrinol Jpn; 1986 Feb; 33(1):51-9. PubMed ID: 2873028
[TBL] [Abstract][Full Text] [Related]
2. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
Gutniak M; Grill V; Efendić S
J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
[TBL] [Abstract][Full Text] [Related]
3. Response of plasma somatostatin-like immunoreactivity (SLI) to a 75 g oral glucose tolerance test in normal subjects and patients with impaired glucose tolerance.
Itoh M; Hirooka Y; Nihei N
Acta Endocrinol (Copenh); 1983 Dec; 104(4):468-74. PubMed ID: 6140806
[TBL] [Abstract][Full Text] [Related]
4. Basal and meal-induced somatostatin-like immunoreactivity in healthy subjects and in IDDM and totally pancreatectomized patients. Effects of acute blood glucose normalization.
Gutniak M; Grill V; Wiechel KL; Efendić S
Diabetes; 1987 Jul; 36(7):802-7. PubMed ID: 2884157
[TBL] [Abstract][Full Text] [Related]
5. Fasting and postprandial concentrations of somatostatin-28 and somatostatin-14 in type II diabetes in men.
D'Alessio DA; Ensinck JW
Diabetes; 1990 Oct; 39(10):1198-202. PubMed ID: 1976558
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin-like immunoreactivity in human peripheral plasma measured by radioimmunoassay following affinity chromatography.
Tsuda K; Sakurai H; Seino Y; Seino S; Tanigawa K; Kuzuya H; Imura H
Diabetes; 1981 Jun; 30(6):471-4. PubMed ID: 6112180
[TBL] [Abstract][Full Text] [Related]
7. Peripheral plasma somatostatin-like immunoreactive responses to insulin hypoglycemia and a mixed meal in healthy subjects and in noninsulin-dependent maturity-onset diabetics.
Vinik AI; Levitt NS; Pimstone BL; Wagner L
J Clin Endocrinol Metab; 1981 Feb; 52(2):330-7. PubMed ID: 6109733
[TBL] [Abstract][Full Text] [Related]
8. Circulating somatostatin concentrations in healthy and non-insulin-dependent (type II) diabetic subjects.
Conlon JM; McCulloch AJ; Alberti KG
Diabetes; 1983 Aug; 32(8):723-9. PubMed ID: 6347769
[TBL] [Abstract][Full Text] [Related]
9. Evidence for the hormonal status of somatostatin in man.
Zyznar ES; Pietri AO; Harris V; Unger RH
Diabetes; 1981 Oct; 30(10):883-6. PubMed ID: 6115787
[TBL] [Abstract][Full Text] [Related]
10. Plasma somatostatin-like immunoreactivity and somatostatin-28 levels in obese men.
Peracchi M; Carola F; Cavagnini F; Benti R; Bareggi B; Baccalaro G; Basilisco G
J Endocrinol Invest; 1998 Jan; 21(1):20-3. PubMed ID: 9633018
[TBL] [Abstract][Full Text] [Related]
11. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
Schusdziarra V; Lawecki J; Ditschuneit HH; Lukas B; Maier V; Pfeiffer EF
Diabetes; 1985 Jun; 34(6):595-601. PubMed ID: 2861127
[TBL] [Abstract][Full Text] [Related]
12. Hypersomatostatinemia in chronic renal failure.
Wasada T; Inoue K; Fujimi S; Sako Y; Hisatomi A; Ibayashi H
Endocrinol Jpn; 1987 Apr; 34(2):251-6. PubMed ID: 2887424
[TBL] [Abstract][Full Text] [Related]
13. Role of circulating somatostatin in regulation of gastric acid secretion, gastrin release, and islet cell function. Studies in healthy subjects and duodenal ulcer patients.
Colturi TJ; Unger RH; Feldman M
J Clin Invest; 1984 Aug; 74(2):417-23. PubMed ID: 6146638
[TBL] [Abstract][Full Text] [Related]
14. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
Schusdziarra V; Rouiller D; Harris V; Unger RH
Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
[TBL] [Abstract][Full Text] [Related]
15. A stimulating effect of glucose on somatostatin release is impaired in noninsulin-dependent diabetes mellitus.
Grill V; Gutniak M; Roovete A; Efendić S
J Clin Endocrinol Metab; 1984 Aug; 59(2):293-7. PubMed ID: 6145723
[TBL] [Abstract][Full Text] [Related]
16. Infusion of graded concentrations of somatostatin in man: pharmacokinetics and differential inhibitory effects on pituitary and islet hormones.
Skamene A; Patel YC
Clin Endocrinol (Oxf); 1984 May; 20(5):555-64. PubMed ID: 6146413
[TBL] [Abstract][Full Text] [Related]
17. [Somatostatin-like activity (SLI) in the blood during metformin treatment of obese patients with diabetes mellitus type 2].
Lawecki J; Stryjek-Kamińska D; Schusdziarra V
Pol Arch Med Wewn; 1989 Mar; 81(3):183-8. PubMed ID: 2576469
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
Berelowitz M; Kronheim S; Pimstone B; Shapiro B
J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
[TBL] [Abstract][Full Text] [Related]
20. Effects of basal insulin supplementation on disposition of mixed meal in obese patients with NIDDM.
McMahon M; Marsh HM; Rizza RA
Diabetes; 1989 Mar; 38(3):291-303. PubMed ID: 2492963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
